Skip to content

Home-Based Tele-Rehabilitation for Respiratory Function in Children With Duchenne Muscular Dystrophy

Feasibility and Preliminary Clinical Effects of a Home-Based, Remotely Delivered Respiratory Rehabilitation Program for Children With Duchenne Muscular Dystrophy

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07629284
Enrollment
12
Registered
2026-06-05
Start date
2026-01-23
Completion date
2027-03-31
Last updated
2026-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duchene Muscular Dystrophy

Keywords

Duchene Muscular Dystrophy, Tele-rehabilitation, Respiratory Function, Home-based Exercise, Caregiver Education

Brief summary

This study evaluates the feasibility and preliminary clinical effects of a home-based tele-rehabilitation program aimed at improving respiratory function in children with Duchenne Muscular Dystrophy (DMD).

Detailed description

This is a prospective single-arm interventional study evaluating a 6-week home-based tele-rehabilitation program for respiratory function in children with Duchenne Muscular Dystrophy. The intervention includes weekly remote education sessions and home-based exercises, with assessments conducted before and after the intervention and a 2-week follow-up for adherence monitoring.

Interventions

BEHAVIORALHome-Based Respiratory Telerehabilitation Program

A 6-week caregiver-assisted home-based respiratory telerehabilitation program for children with Duchenne muscular dystrophy. The program includes weekly remote education sessions, respiratory muscle exercises, airway clearance training, relaxation positioning, and self-directed home exercises performed at least 5 times per week. Outcomes are assessed before and after the intervention and at 2-week follow-up.

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Children aged 3 years or older with genetically confirmed Duchenne muscular dystrophy * Participants who are able to understand the study procedures and appropriately participate in the study

Exclusion criteria

* Requirement for daytime ventilator support or invasive mechanical ventilation via tracheostomy (nighttime non-invasive ventilation such as positive airway pressure ventilation is allowed) * History of peripheral nerve injury * History of major surgery within 12 weeks prior to enrollment or expected major surgery during the study period * History of central nervous system disorders (e.g., cerebral infarction or spinal cord injury) * Severe cognitive impairment or other conditions that may interfere with participation in the study procedures

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of the Home-Based Respiratory Tele-rehabilitation ProgramBaseline to immediately after the 6-week interventionFeasibility of the home-based respiratory telerehabilitation program will be assessed using exercise adherence rate, session attendance rate, and exercise log completion during the 6-week intervention period. These measures will be summarized descriptively as indicators of program feasibility. Higher percentages indicate better feasibility.
Acceptability of the Home-Based Respiratory Tele-rehabilitation ProgramImmediately after the 6-week intervention and at 2-week follow-upAcceptability of the home-based respiratory telerehabilitation program will be assessed using caregiver-reported satisfaction, perceived exercise difficulty, caregiver burden, and child participation questionnaires during the intervention period. Higher satisfaction and participation scores indicate greater acceptability, whereas higher perceived difficulty and caregiver burden scores indicate lower acceptability.

Secondary

MeasureTime frameDescription
Inspiratory Muscle StrengthBaseline and immediately after the 6-week interventionInspiratory muscle strength will be assessed using maximal inspiratory pressure (MIP). Measurements will be recorded in centimeters of water pressure (cmH2O). Higher values indicate greater inspiratory muscle strength.
Expiratory Muscle StrengthBaseline and immediately after the 6-week interventionExpiratory muscle strength will be assessed using maximal expiratory pressure (MEP). Measurements will be recorded in centimeters of water pressure (cmH2O). Higher values indicate greater expiratory muscle strength.
Respiratory Muscle FunctionBaseline and immediately after the 6-week interventionRespiratory muscle function will be assessed using inspiratory muscle endurance time, surface electromyography (sEMG) of the sternocleidomastoid muscle, and respiratory muscle ultrasonography. Inspiratory muscle endurance will be measured in seconds, and respiratory muscle thickness will be measured in millimeters (mm). Higher endurance time and greater muscle thickness indicate improved respiratory muscle function.
Physical Functional PerformanceBaseline and immediately after the 6-week interventionPhysical functional performance will be assessed using the Vignos Scale, Brooke Upper Extremity Functional Rating Scale, and North Star Ambulatory Assessment (NSAA). The Vignos Scale ranges from 1 to 10, with higher scores indicating greater lower extremity disability. The Brooke Scale ranges from 1 to 6, with higher scores indicating greater upper extremity functional limitation. The NSAA ranges from 0 to 34, with higher scores indicating better motor function.
Functional Exercise CapacityBaseline and immediately after the 6-week interventionFunctional exercise capacity will be assessed using the 6-Minute Walk Test (6MWT). Total walking distance will be recorded in meters. Greater walking distance indicates better functional exercise capacity.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 6, 2026